HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jolanta Karpinski Selected Research

Creatinine

4/2023Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients.
3/2012Change in appropriate referrals to nephrologists after the introduction of automatic reporting of the estimated glomerular filtration rate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jolanta Karpinski Research Topics

Disease

2Infections
04/2023 - 03/2017
1COVID-19
04/2023
1Acute Kidney Injury (Acute Renal Failure)
04/2023
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Neoplasms (Cancer)
01/2021
1Listeriosis (Listeria Infection)
03/2017
1Peritonitis
03/2017
1Chronic Renal Insufficiency
03/2012
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2008
1Dyslipidemias (Dyslipidemia)
01/2007
1Hypertension (High Blood Pressure)
01/2007
1Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
12/2005

Drug/Important Bio-Agent (IBA)

2CreatinineIBA
04/2023 - 03/2012
1nirmatrelvir and ritonavir drug combinationIBA
04/2023
1Tacrolimus (Prograf)FDA LinkGeneric
04/2023
1VancomycinFDA LinkGeneric
03/2017
1Ampicillin (Omnipen)FDA LinkGeneric
03/2017
1Gentamicins (Gentamicin)FDA LinkGeneric
03/2017
1Rituximab (Mabthera)FDA Link
01/2008
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2007
1ErythropoietinFDA Link
01/2007
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2007
1Sirolimus (Rapamycin)FDA Link
12/2005

Therapy/Procedure

3Therapeutics
01/2021 - 01/2008
1Peritoneal Dialysis
03/2017
1Plasmapheresis
01/2008
1Kidney Transplantation
12/2005